Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
The Journal of Headache and Pain
Published in: The Journal of Headache and Pain 1/2014

Open Access 01-12-2014 | Meeting abstract

EHMTI-0080. How migraine is affected by therapies for multiple sclerosis

Authors: C Condello, L Pinessi, L Savi

Published in: The Journal of Headache and Pain | Special Issue 1/2014

Login to get access

Excerpt

There are a number of available disease-modifying therapies for Multiple Sclerosis (MS). Prevalence of migraine is higher in SM patients than in the general population, so possible effects of these preventive treatments on migraine should be monitored. A review of the literature on the subject is presented. …
Metadata
Title
EHMTI-0080. How migraine is affected by therapies for multiple sclerosis
Authors
C Condello
L Pinessi
L Savi
Publication date
01-12-2014
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 1/2014
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-15-S1-D11

Other articles of this Special Issue 1/2014

The Journal of Headache and Pain 1/2014 Go to the issue

Meeting abstract

EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception

Meeting abstract

EHMTI-0328. Comparative evaluation of pregabalin, gabapentin, carbamazepine and topiramat in migraine

Meeting abstract

EHMTI-0179. Emotive and behavior problems in adolescents with cronic headache (CDH) and medication overuse (MOH) using child behaviour checklist(CBCL) e youth self-report (YSR)

Meeting abstract

EHMTI-0252. The frequency of acute medication intake relates to its perceived effectiveness in chronic headache patients

Meeting abstract

EHMTI-0394. Predictive parameters for the effect of botulinum toxin infiltrations in chronic migraine

Meeting abstract

EHMTI-0354. Abnormal expression of gene transcripts linked to inflammatory response in the periosteum of chronic migraine patients: implications to extracranial origin of headache